Replimune (REPL) Change in Accured Expenses (2017 - 2025)

Replimune has disclosed Change in Accured Expenses across 9 years of filings, most recently posting -$1.9 million for Q4 2025.

• Change in Accured Expenses for Q4 2025 came in at -$1.9 million, down 136.4% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.6 million (down 18.69% YoY), and the FY2025 annual result was $11.7 million, up 27.17% from the prior year.
• Change in Accured Expenses came in at -$1.9 million for Q4 2025 at Replimune, down from $2.8 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $9.2 million in Q1 2025 to a low of -$5.5 million in Q2 2025.
• The 5-year median for Change in Accured Expenses is $1.2 million (2021), against an average of $1.7 million.
• Across the five-year window, Change in Accured Expenses soared 4245.45% in 2021 and sank 333.99% in 2022, its largest moves.
• Replimune's Change in Accured Expenses stood at $754000.0 in 2021, then surged by 277.45% to $2.8 million in 2022, then slumped by 130.01% to -$854000.0 in 2023, then soared by 715.46% to $5.3 million in 2024, then tumbled by 136.4% to -$1.9 million in 2025.
• The last three Change in Accured Expenses figures came in at -$1.9 million (Q4 2025), $2.8 million (Q3 2025), and -$5.5 million (Q2 2025), per Business Quant data.